Join
Live feed
·
PRReleasevia Quantisnow
Equillium Inc. logo

Equillium Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis

ByQuantisnow·Wall Street's wire, on your screen.
EQ· Equillium Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EQ (Equillium Inc.) and more on Quantisnow.